Lyra Therapeutics, Inc. (LYRA)
0.19
0.00 (0.00%)
USD |
OTCM |
Oct 14, 16:00
Lyra Therapeutics Total Assets (Quarterly) : 36.11M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 36.11M |
| September 30, 2025 | 43.71M |
| June 30, 2025 | 52.57M |
| March 31, 2025 | 56.32M |
| December 31, 2024 | 66.35M |
| September 30, 2024 | 78.76M |
| June 30, 2024 | 94.58M |
| March 31, 2024 | 141.53M |
| December 31, 2023 | 142.60M |
| September 30, 2023 | 120.58M |
| June 30, 2023 | 125.68M |
| March 31, 2023 | 93.87M |
| December 31, 2022 | 109.97M |
| Date | Value |
|---|---|
| September 30, 2022 | 119.46M |
| June 30, 2022 | 130.04M |
| March 31, 2022 | 47.34M |
| December 31, 2021 | 54.87M |
| September 30, 2021 | 67.76M |
| June 30, 2021 | 76.33M |
| March 31, 2021 | 72.92M |
| December 31, 2020 | 80.83M |
| September 30, 2020 | 87.33M |
| June 30, 2020 | 92.72M |
| March 31, 2020 | 40.77M |
| December 31, 2019 | 14.96M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 103.90M |
| CorMedix, Inc. | 904.05M |
| Eloxx Pharmaceuticals, Inc. | 63.39M |
| Breakthrough Chemistry, Inc. | 1.300M |
| BioStem Technologies, Inc. | 48.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.82M |
| Shareholders Equity (Quarterly) | -10.72M |
| Debt to Equity Ratio | -2.824 |
| Current Ratio | 1.709 |
| Net Debt Paydown Yield | 18.53% |